Showing results (1611-1620 of 2,335) with videos related to

Sort By:
Pageof 234
The Journal of Allergy and Clinical Immunology. Global|November 28, 2025
Prediction model to identify patients with hypereosinophilic syndrome using real-world dataPaneez Khoury, Yen Chung, Donna Carstens, et al.
Pigment Cell & Melanoma Research|March 4, 2026
QUILPEN Provides Independent and Label-Free Single-Cell Quantification of Pigmentation Dynamics and Organelle ContentRebecca G Zitnay, Shukran Alizada, Tarek E Moustafa, et al.
Head & Neck|March 26, 2026
Biomarkers Associated With Extranodal Extension (ENE) in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Systematic ReviewLauren C Williams, Naishaliz Lorenzo, Alexander Ladenheim, et al.
Translational Animal Science|October 5, 2020
South Dakota State University Beef 2020 increases participant knowledge of the beef industryChristina E Bakker, Keith R Underwood, Judson K Grubbs, et al.
The Annals of Thoracic Surgery|May 20, 2019
Impact of Microbiological Organism Type on Surgically Managed EndocarditisJudson B Williams, Asad A Shah, Shuaiqi Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancerCarol Aghajanian, Stephanie V Blank, Barbara A Goff, et al.
Hepatology (Baltimore, Md.)|June 1, 1989
Delta hepatitis in homosexual men in the United StatesI B Weisfuse, S C Hadler, H A Fields, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 18, 2016
Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical LibrariesKatie Paul Friedman, Eric D Watt, Michael W Hornung, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to miceF I Raynaud, R M Orr, P M Goddard, et al.
Pageof 234